 |
市場調査レポート
商品コード
1539557
デジタルPCRの市場規模、シェア、成長分析：オファリング別、エンドユーザー別、用途別、地域別 - 産業予測、2024年～2031年Digital PCR Market Size, Share, Growth Analysis, By Offerings, By End User, By Application, By Region - Industry Forecast 2024-2031 |
||||||
| デジタルPCRの市場規模、シェア、成長分析：オファリング別、エンドユーザー別、用途別、地域別 - 産業予測、2024年～2031年 |
|
出版日: 2024年08月12日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のデジタルPCRの市場規模は、2022年に68億3,000万米ドルとなり、予測期間（2024年～2031年）のCAGRは9.02%で、2023年の85億米ドルから、2031年までには158億6,000万米ドルに成長する見通しです。
世界のデジタルPCR（ポリメラーゼ連鎖反応）市場は、精密で高感度な核酸定量・分析へのニーズの高まりにより、急速な成長を遂げています。デジタルPCRは、その正確さと感度が高く評価され、遺伝子検査、疾病診断、研究に欠かせないものとなっています。同市場は、ヘルスケア専門家、臨床検査室、研究者に正確で信頼性の高い結果を提供し、最終的に患者ケアと科学の進歩を強化する先進的な分子診断ツールを提供することを目指しています。遺伝性疾患や感染症の罹患率の増加、個別化医療に対する需要の高まり、ゲノム研究の進展など、いくつかの要因が市場の拡大を後押ししています。しかし、デジタルPCR装置の高価格や潜在的ユーザーの認知度の低さといった課題も抱えています。主要な市場動向としては、デジタルPCRと次世代シーケンサー技術の統合や、複数のターゲットを同時に検出できるマルチプレックスデジタルPCRアッセイの市場開拓などが挙げられます。このような課題にもかかわらず、市場には大きな成長機会があります。その背景には、新興国でのデジタルPCR採用の増加、腫瘍学および感染症診断におけるデジタルPCRの役割の拡大、機能を強化した革新的製品の継続的な採用があります。
目次
イントロダクション
- 調査の目的
- 定義
- 市場範囲
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模予測
- 市場の前提条件と制限
エグゼクティブサマリー
- 市場概要見通し
- 供給需要動向分析
- セグメント別機会分析
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- ポーターの分析
主要な市場の考察
- 市場の主要な成功要因
- 競合の程度
- 主要な投資機会
- 市場魅力度指数
- エコシステムマッピング
- 価格分析
- 特許分析
- 貿易分析
- 技術分析
- サプライチェーン分析
- バリューチェーン分析
デジタルPCR市場：オファリング別
- QPCRオファリング
- QPCR製品
- QPCR試薬・消耗品
- QPCR機器
- QPCRソフトウェア
- QPCRサービス
- QPCR製品
- DPCRオファリング
- DPCR試薬・消耗品
- DPCR機器
- ドロップレットデジタルPCR
- チップベースデジタルPCR
- BEAMingデジタルPCR
- DPCRソフトウェア
- DPCRサービス
デジタルPCR市場：用途別
- QPCR・DPCR用途
- 臨床応用
- 感染症検査
- 腫瘍学検査
- 血液検査
- 移植診断
- その他
- 調査用途
- 単一細胞解析
- 幹細胞調査
- 遺伝子発現
- その他
- 法医学用途
- 環境用途
- その他
デジタルPCR市場：エンドユーザー別
- QPCR & DPCRエンドユーザー
- 病院・診断研究所
- 学術・研究機関
- 製薬・バイオテクノロジー企業
- CRO・CDMO
- 法医学研究所
- その他
デジタルPCR市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2023年）
- 主要な市場企業が採用した戦略
- 市場における最近の活動
- 主要企業の市場シェア（2023年）
主要企業プロファイル
- Thermo Fisher Scientific（US）
- Bio-Rad Laboratories（US）
- QIAGEN（Germany）
- F. Hoffmann-La Roche Ltd（Switzerland）
- Fluidigm Corporation（US）
- Merck KGaA（Germany）
- Agilent Technologies（US）
- BioMerieux SA（France）
- Takara Bio Inc.（Japan）
- Danaher Corporation（US）
- JN Medsys（Singapore）
- Formulatrix, Inc.（US）
- Stilla Technologies（France）
- Becton, Dickinson and Company（US）
- Sysmex Corporation（Japan）
- Quantabio（US）
- Illumina, Inc.（US）
- Promega Corporation（US）
- Eppendorf AG（Germany）
- PerkinElmer, Inc.（US）
- LGC Biosearch Technologies（UK）
Global Digital PCR Market size was valued at USD 6.83 Billion in 2022 and is poised to grow from USD 8.5 Billion in 2023 to USD 15.86 Billion by 2031, at a CAGR of 9.02 % during the forecast period (2024-2031).
The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth, driven by the rising need for precise and sensitive nucleic acid quantification and analysis. Digital PCR is highly valued for its accuracy and sensitivity, making it crucial for genetic testing, disease diagnosis, and research. The market aims to deliver advanced molecular diagnostic tools that provide healthcare professionals, clinical laboratories, and researchers with accurate and reliable results, ultimately enhancing patient care and scientific progress. Several factors propel the market's expansion, including the increasing incidence of genetic disorders and infectious diseases, the growing demand for personalized medicine, and advancements in genomic research. However, the market also contends with challenges such as the high cost of digital PCR equipment and limited awareness among potential users. Key market trends include the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays that allow for the simultaneous detection of multiple targets. Despite these challenges, the market offers substantial growth opportunities. This is driven by the rising adoption of digital PCR in emerging economies, its expanding role in oncology and infectious disease diagnostics, and the ongoing introduction of innovative products with enhanced capabilities.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Digital PCR market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Digital PCR Market Segmental Analysis
Global Digital PCR Market is segmented based on offering, end user, application, and region. Based on offering, the market is segmented into qPCR Offering [qPCR Products (qPCR Reagents and Consumables, qPCR Instruments), qPCR Software, dPCR Services], dPCR Offerings [dPCR Reagents and Consumables, dPCR Instruments (Droplet digital PCR, Chip-based digital PCR, Beaming digital PCR), dPCR Software, dPCR Services]. Based on end user, the market is segmented into qPCR End Users and dPCR End Users [Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, Other End Users]. Based on application, the market is segmented into Clinical Applications [Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, Other Clinical Applications], Research Applications [Single-cell analysis, Stem cell research, Gene expression, Others], Forensic Applications, Environmental Applications, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Digital PCR Market
Technological advancements in digital polymerase chain reaction (dPCR) are set to greatly impact market growth. These innovations represent a notable shift from traditional PCR methods, providing direct nucleic acid quantification and clonal amplification. The rising demand for state-of-the-art dPCR devices, alongside heightened research and development efforts, has led to the emergence of advanced PCR technologies that deliver significant advantages. This progress underscores the transformative potential of dPCR in improving molecular diagnostics and research outcomes.
Restraints in the Global Digital PCR Market
The uptake of digital PCR technology may be constrained by the significant initial costs involved in acquiring the necessary instruments and reagents. Digital PCR systems demand specialized equipment and consumables, which can be costly for research labs and smaller healthcare facilities. These high expenses might restrict access to digital PCR technology, particularly in resource-limited environments or for researchers operating with tight budgets.
Market Trends of the Global Digital PCR Market
Digital PCR and next-generation sequencing (NGS) technologies are complementary and can be integrated for a more comprehensive genomic analysis. By combining digital PCR's precise quantification capabilities with NGS's sequencing data, researchers gain access to both qualitative and quantitative insights. This integration enhances the identification of rare genetic variants, validates NGS findings, and allows for the detailed analysis of complex genomic changes associated with diseases.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors of The Market
- Degree Of Competition
- Top Investment Pockets
- Market Attractive Index
- Ecosystem Mapping
- Pricing Analysis
- Patent Analysis
- Trade Analysis
- Technology Analysis
- Supply Chain Analysis
- Value Chain Analysis
Global Digital PCR Market by Offering
- QPCR Offering
- QPCR Products
- QPCR Reagents and Consumables
- QPCR Instruments
- QPCR Software
- QPCR Services
- QPCR Products
- DPCR Offering
- DPCR Reagents and Consumables
- DPCR Instruments
- Droplet digital PCR
- Chip-based digital PCR
- Beaming digital PCR
- DPCR Software
- DPCR Services
Global Digital PCR Market by Application
- QPCR & DPCR Application
- Clinical Applications
- Infectious Disease Testing
- Oncology Testing
- Blood Screening
- Transplant Diagnostics
- Others
- Research Applications
- Single-cell analysis
- Stem cell research
- Gene expression
- Others
- Forensic Applications
- Environmental Applications
- Others
Global Digital PCR Market by End-User
- QPCR & DPCR End-User
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- CROs and CDMOs
- Forensic Laboratories
- Others
Global Digital PCR Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JN Medsys (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Formulatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stilla Technologies (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quantabio (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LGC Biosearch Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
